Nostrum Biodiscovery collaborates in a research project against COVID-19
Nostrum Biodiscovery –a spin-off from thethe University of Barcelona (UB), Institute for Research in Biomedicine (IRB Barcelona), the Barcelona Supercomputing Centre (BSC-CNS), and the Catalan Institution for Research and Advanced Studies (ICREA) , located at the Barcelona Science Park and the North Campus of the Universitat Politècnica de Catalunya (UPC)– collaborates by providing data that facilitates the smart, in silico design of SARS-CoV-2-related drugs. The conclusions of its work will be offered altruistically to this consortium and to other international projects in which BSC-CNS is participating to tackle the COVID-19 virus, such as EXSCALATE4CoV (E4C). “The impact of computational simulation on the drug discovery process is increasingly significant. Public and private research groups are making increasing use of in silico technologies, which, as they are directly related to the increased computing power of computers, are increasingly powerful and significantly reduce the time and cost of developing a drug”, explains Modesto Orozco, Chairman of NBD.